A significant advance in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant protector protein is frequently inactivated in several forms of cancer, https://captainbookmark.com/story21871099/nanobodies-reactivate-tumor-suppressor-p53-a-promising-hope-for-malignant-management